Did you know? Not all hypertrophic cardiomyopathy is sarcomeric. Nearly 40% of patients have HCM phenocopies—such as amyloidosis, Fabry disease, or metabolic disorders—that mimic classic HCM but differ in prognosis and treatment. Integrating ECG, echocardiography, cardiac MRI, and genetic testing is essential to ensure accurate diagnosis and guide disease-specific management.
Could routinely screening for HCM phenocopies help cardiologists avoid misdiagnosis and enable earlier, targeted interventions?

Could routinely screening for HCM phenocopies help cardiologists avoid misdiagnosis and enable earlier, targeted interventions?

